Industry | 制造业 | ||||||||||||||||||||||||
Company Introduction | 江苏四环生物股份有限公司是一家以生物医学技术及传统医药相结合的现代化药品生产企业,主营肝炎诊断试剂、注射剂、体外诊断试剂等.主要产品有重组人白细胞介素-2、重组人表皮生长因子、重组人粒细胞集落刺激因子、重组人红细胞生成素、肝炎诊断试剂、体外诊断试剂、注射剂等.公司拥有年产2000万瓶(袋)的输液车间,3亿支的针剂车间,30亿片(粒)的固体制剂车间,500万瓶的中药酒剂车间,年产1000吨的原料车间.公司还拥有从国外引进的非PVC软包输液生产线、傅立叶红外光谱仪、水处理系统、胶囊填充机等先进设备。 | ||||||||||||||||||||||||
Main Business | 主要从事生物医药制品、生产和销售以及园林绿化工程业务。 | ||||||||||||||||||||||||
Legal Representative | 郭煜 | ||||||||||||||||||||||||
Top Executives |
|
||||||||||||||||||||||||
Top 5 Shareholder |
|
||||||||||||||||||||||||
Company Secretary | 郭煜 | ||||||||||||||||||||||||
Solicitors | 江苏世纪同仁律师事务所 | ||||||||||||||||||||||||
Auditors | 江苏公证会计师事务所有限公司 | ||||||||||||||||||||||||
Tel No | 0510-86408558 | ||||||||||||||||||||||||
Fax No | 0510-86408558 | ||||||||||||||||||||||||
Website | www.000518shsw.com | ||||||||||||||||||||||||
0518shsw@163.com | |||||||||||||||||||||||||
Company Address |
|
||||||||||||||||||||||||
Listing Date | 08/09/1993 | ||||||||||||||||||||||||
Shares Capital |
|
||||||||||||||||||||||||
EPS(RMB)* | ¥ -0.073 | ||||||||||||||||||||||||
DPS(RMB)* | -- | ||||||||||||||||||||||||
NBV Per Share(RMB)* | ¥ 0.468 | ||||||||||||||||||||||||
Market Capitalization(RMB) | 3.480B |
Only Chinese content is avaliable | |
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
* | Unadjusted Data |
Information provided by: etnet | ||
Terms and Conditions |
Risk Disclosure: |
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
Disclaimer: |
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |